Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain

R Schwarcz, WO Whetsell Jr, RM Mangano - Science, 1983 - science.org
A current hypothesis links the neuroexcitatory properties of certain acidic amino acids to
their ability to cause selective neuronal lesions. Intracerebral injection of the neuroexcitatory …

Kynurenines in the mammalian brain: when physiology meets pathology

R Schwarcz, JP Bruno, PJ Muchowski… - Nature Reviews …, 2012 - nature.com
The essential amino acid tryptophan is not only a precursor of serotonin but is also
degraded to several other neuroactive compounds, including kynurenic acid, 3-hydroxykynurenine …

Blood–brain barrier transport of kynurenines: implications for brain synthesis and metabolism

S Fukui, R Schwarcz, SI Rapoport… - Journal of …, 1991 - Wiley Online Library
To evaluate the potential contribution of circulating kynurenines to brain kynurenine pools,
the rates of cerebral uptake and mechanisms of blood–brain barrier transport were …

Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea

JT Coyle, R Schwarcz - Nature, 1976 - nature.com
THE symptoms of Huntington's chorea, an hereditary movement disorder, result from
degeneration of neurones primarily in the basal ganglia 1 . Several neurochemical abnormalities …

The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression: physiopathological implications

…, M Alkondon, A Rassoulpour, R Schwarcz… - Journal of …, 2001 - Soc Neuroscience
The tryptophan metabolite kynurenic acid (KYNA) has long been recognized as an NMDA
receptor antagonist. Here, interactions between KYNA and the nicotinic system in the brain …

Increased cortical kynurenate content in schizophrenia

R Schwarcz, A Rassoulpour, HQ Wu, D Medoff… - Biological …, 2001 - Elsevier
Background: Metabolites of the kynurenine pathway of tryptophan degradation may play a
role in the pathogenesis of several human brain diseases. One of the key metabolites in this …

Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities

R Schwarcz, R Pellicciari - Journal of Pharmacology and Experimental …, 2002 - ASPET
Degradation of the essential amino acid tryptophan along the kynurenine pathway (KP)
yields several neuroactive intermediates, including the free radical generator 3-…

[HTML][HTML] Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration

…, Y Huang, JM Muchowski, E Masliah, R Schwarcz… - Cell, 2011 - cell.com
Metabolites in the kynurenine pathway, generated by tryptophan degradation, are thought
to play an important role in neurodegenerative disorders, including Alzheimer's and …

Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid

AC Foster, A Vezzani, ED French, R Schwarcz - Neuroscience letters, 1984 - Elsevier
Kynurenic acid (KYNA) was tested as an antagonist of the neurotoxic and epileptogenic
effects of the metabolically related brain constituent quinolinic acid (QUIN). In the rat striatum, …

External versus endoscopic dacryocystorhinostomy for acquired nasolacrimal duct obstruction in a tertiary referral center

GJB Simon, J Joseph, S Lee, RM Schwarcz… - Ophthalmology, 2005 - Elsevier
PURPOSE: To compare success rates of external dacryocystorhinostomy (DCR) and
endoscopic endonasal DCR for acquired nasolacrimal duct obstruction (NLDO). DESIGN: …